Cargando…
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with funding new medicines at ever increasing prices along with funding increased medicine volumes with the...
Ejemplares similares
-
The Expiry of Humira(®) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
por: Moorkens, Evelien, et al.
Publicado: (2021) -
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
por: Godman, Brian, et al.
Publicado: (2021) -
Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
por: Godman, Brian, et al.
Publicado: (2023) -
Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications
por: Jakupi, Arianit, et al.
Publicado: (2018) -
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
por: Vella Bonanno, Patricia, et al.
Publicado: (2017)